<?xml version="1.0" encoding="UTF-8"?>
<p>In the meantime, new human diseases keep emerging. As noted, in late 2012 the novel MERS coronavirus emerged in Saudi Arabia 
 <xref rid="ppat.1003467-vanBoheemen1" ref-type="bibr">[13]</xref>, and in early 2013 a new H7N9 avian influenza virus became epizootic in Eastern China, causing 132 spillover infections of humans (as of June 7, 2013), with 28 percent case fatality 
 <xref rid="ppat.1003467-World1" ref-type="bibr">[10]</xref>, 
 <xref rid="ppat.1003467-Li1" ref-type="bibr">[22]</xref>. Its pandemic potential, if any, remains to be determined. Whether or not such outbreaks become more widespread, they nonetheless attract global attention and require significant international effort to monitor and contain. Microbial advantages can be met and overcome only by aggressive vigilance, ongoing dedicated research, and rapid development and deployment of such countermeasures as surveillance tools, diagnostics, drugs, and vaccines.
</p>
